Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

96-88-8

Mepivacaine

96-88-8
22916-47-8

Miconazole

22916-47-8
2919-66-6

Melengestrol acetate

2919-66-6
13182-89-3

Metronidazole benzoate

13182-89-3
2013-58-3

Meclocycline

2013-58-3
57-53-4

Meprobamate

57-53-4
60-56-0

Methimazole

60-56-0
13341-72-5

Menthalactone

13341-72-5
58-18-4

Methyltestosterone

58-18-4
13422-55-4

Methylcobalamin

13422-55-4
41372-08-1

Methyldopa

41372-08-1
1721-93-3

Methylisoquinoline-1

1721-93-3
90-33-5

Methylumbelliferone-4

90-33-5
15220-11-8

Methylumbelliferyl-4 sulfate potassium salt

15220-11-8
61-73-4

Methylene Blue

61-73-4
521-11-9

Mestanolone

521-11-9
96036-03-2

Meropenem

96036-03-2
86347-15-1

Medetomidine Hydrochloride

86347-15-1
13614-98-7

Minocycline Hydrochloride

13614-98-7
59-05-2

Methotrexate

59-05-2